Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease

Br J Haematol. 2023 May;201(3):573-576. doi: 10.1111/bjh.18712. Epub 2023 Mar 1.

Authors

Fernando De la Garza-Salazar¹, Perla Rocío Colunga-Pedraza¹, Edgar Ulises Coronado-Alejandro¹, César Homero Gutiérrez-Aguirre¹, Olga Graciela Cantú-Rodríguez¹, David Gómez-Almaguer¹

Affiliation

¹ Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González", Hematology Service, Internal Medicine Department, Universidad Autónoma de Nuevo León, Monterrey, Mexico.

PMID: 36859646
DOI: 10.1111/bjh.18712

No abstract available

Keywords: CYP; chronic graft versus host disease; ibrutinib; itraconazole; low dose.

Publication types

Letter

MeSH terms

B-Lymphocytes
Bronchiolitis Obliterans Syndrome*
Chronic Disease
Graft vs Host Disease* / drug therapy
Graft vs Host Disease* / etiology
Hematopoietic Stem Cell Transplantation*
Humans
Piperidines
Steroids

Substances

ibrutinib
Piperidines
Steroids